SubHero Banner

Moderna and Pfizer/BioNTech COVID-19 vaccines, bivalent (Original and Omicron BA.4/BA.5) – New emergency use authorizations

August 31, 2022 - The FDA announced the emergency use authorization (EUA) of two new updated COVID-19 vaccines: Moderna’s COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) and Pfizer/BioNTech’s COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5). Both vaccines are authorized for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Download PDF